Displaying 1 (all) recruiting clinical trials.
-
AN OPEN-LABEL MULTICENTER PHASE 1/2 STUDY TO EVALUATE THE SAFETY AND EFFICACY OF AB-3028 IN PATIENTS WITH CASTRATION RESISTANT PROSTATE CANCER (CRPC)
This is a Phase 1/2 study to test how safe different doses of the chimeric antigen receptor (CAR-T) medicine AB-3028 are for adults with ...
Phase
Interventional
